ARCHIVES

FDA Oncologic Drugs Advisory Committee: Trials In A Small Indication Tell Big Story About Pitfalls of Delaying Progression

This article is from The Cancer Letter archive.

Vol. 37 No. 15 | April 15, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: fraud By Trainee Leads Collins To Retract Five Paper; Weinstein Retires At Columbia

November 1, 1996

In Brief: Pazdur to direct FDA Oncology Division; Ganz Awarded ACS Clinical Professorship

July 23, 1999

Pharmaceutical Industry: IVAX Official Broder Objects To Orphan Drug Policies of FDA

May 9, 1997

NCI-Approved Clinical Trials Listed For Month Of March

April 27, 2001

ACS Urged To Put More Resources Into Psychosocial Research

May 8, 1981

Program Announcement For Clinical Research

February 29, 1980